Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05521919 · ClinicalTrials.gov registry record · NA
Acute Plasma Abeta Responses to Stress
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT05521919 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 38 participants.
The verdict
NCT05521919, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
Research has shown that activation of the sympathetic nervous system for extended periods or during certain times in life can increase the risk for Alzheimer's disease. Some research in animal models show that acute activation of the sympathetic nervous system through stress exposure can increase certain Alzheimer's disease-related biomarkers, such as amyloid-beta, within hours of exposure. However, how acute sympathetic nervous system activation via stress exposure affects amyloid-beta levels in humans has yet to be examined. In this study, the investigators will examine whether brief increases in sympathetic activation result in immediate changes in plasma amyloid-beta levels in the five hours after exposure.
Interventions
- BEHAVIORAL Sympathetic Nervous System Activation
- BEHAVIORAL No-stress
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2023-12-05 |
| Est. Completion | 2024-12-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05521919
The ClinicalTrials.gov registry entry for NCT05521919 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sympathetic Nervous System Activation is the first listed.
NCT05521919 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05521919 about?
NCT05521919 is a clinical study titled "Acute Plasma Abeta Responses to Stress". Research has shown that activation of the sympathetic nervous system for extended periods or during certain times in life can increase the risk for Alzheimer's disease. Some research in animal models show that acute activation of the sympathetic nervous system through stress exposure can increase ce...
What is the current status of trial NCT05521919?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2023-12-05. Estimated completion is 2024-12-10.
What interventions are being tested in trial NCT05521919?
The interventions under investigation include: Sympathetic Nervous System Activation (BEHAVIORAL), No-stress (BEHAVIORAL).
Who is sponsoring clinical trial NCT05521919?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.